calendar
3,953 catalysts · 3,827 phase readout · 2,126 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
3,953 catalysts · 3,827 phase readout · 2,126 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
Sponsor: Sirius Therapeutics Co., Ltd.. Phase: PHASE2. Conditions: Coronary Artery Disease (CAD), Peripheral Arterial Disease
Sponsor: Allogene Therapeutics. Phase: PHASE1. Conditions: Relapsed/Refractory Large B Cell Lymphoma, Relapsed/Refractory Follicular Lymphoma
Sponsor: University of Florida. Phase: PHASE2. Conditions: Smoking
Sponsor: Dhaka Medical College. Phase: PHASE3. Conditions: Anemia
Sponsor: Peter Merkel. Phase: . Conditions: Cryoglobulinemic Vasculitis (CV), Drug-induced Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), IgA Vasculitis, Isolated Cutaneous Vasculitis, Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Urticarial Vasculitis, Vasculitis
Sponsor: Shandong University. Phase: . Conditions: Small Bowel Diseases
Sponsor: Friedrich-Alexander-Universität Erlangen-Nürnberg. Phase: NA. Conditions: Gastrointestinal Motility Disorders in Children, Hirschsprung Disease, Constipation - Functional
Sponsor: Genzyme, a Sanofi Company. Phase: . Conditions: Glycogen Storage Disease Type II, Pompe Disease
Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: NA. Conditions: Preoperative Anxiety, Cesarean Section, Surgical Stress Response, Cortisol
Sponsor: Takeda. Phase: PHASE4. Conditions: Multiple Myeloma
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Hodgkin Lymphoma Survivor
Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Knee Osteoarthritis
Sponsor: Mansoura University. Phase: PHASE4. Conditions: Heart Failure
Sponsor: University of Liege. Phase: NA. Conditions: Multiple Sclerosis, Rehabilitation, Neuro-Degenerative Disease, Neurorehabilitation
Sponsor: Institut Saint Pierre. Phase: . Conditions: Aortic Coarctation, Retrospective Studies, Cohort Studies, Hypertension, Risk Factors, Infant, Newborn, Postoperative Complications, Reoperation, Mortality, Death, Cardiac Surgery
Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Uveitis
Sponsor: Vanderbilt University Medical Center. Phase: . Conditions: Postural Orthostatic Tachycardia Syndrome, Acute Hepatic Porphyria
Sponsor: Fundación Universidad Católica de Valencia San Vicente Mártir. Phase: . Conditions: Postural Balance, Foot Posture, Sports Injuries, Athletic Performance
Sponsor: St. Jude Children's Research Hospital. Phase: NA. Conditions: Childhood Cancer Survivor, Chronic Pain
Sponsor: Idoven 1903 S.L.. Phase: . Conditions: Cardiomyopathies, Cardiac Arrest, Cardiac Arrhythmias, Sudden Cardiac Death
Sponsor: Melanoma Institute Australia. Phase: PHASE2. Conditions: Melanoma Metastatic
Sponsor: Vanderbilt-Ingram Cancer Center. Phase: NA. Conditions: Stage I Lung Cancer, Stage II Lung Cancer
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica. Phase: PHASE2. Conditions: ccRCC
Sponsor: Remote Cardiac Enablement. Phase: . Conditions: High Grade Obstructive NSTE-ACS
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Pre-Exposure Prophylaxis, STI, Contraceptive Usage
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 2
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Chronic Myelomonocytic Leukemia, IDH2 Gene Mutation, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Sponsor: Arialys Australia Pty Ltd. Phase: PHASE2. Conditions: Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease, Autoimmune Encephalitis
Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.. Phase: NA. Conditions: Parenting Practices, Self Efficacy, Stress, Child Behavior, Emotional Adjustment, Sleep Problem, Parent-Child Relations
Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Schizophrenia Spectrum Disorder
Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Rheumatoid Arthritis
Sponsor: Xijing Hospital. Phase: NA. Conditions: Severe Stroke, Enteral Nutrition
Sponsor: sara nabil. Phase: PHASE3. Conditions: Reversal of Local Anesthesia in Children
Sponsor: Acoustic Wave Cell Therapy, Inc.. Phase: NA. Conditions: Stress Urinary Incontinence (SUI)
Sponsor: Umeå University. Phase: NA. Conditions: Hernia, Hernia, Ventral, Hernia Incisional, Hernia, Umbilical
Sponsor: Baycrest. Phase: NA. Conditions: Major Depressive Disorder (MDD)
Sponsor: NHS Greater Glasgow and Clyde. Phase: PHASE2. Conditions: Heart Failure
Sponsor: Hospital for Special Surgery, New York. Phase: NA. Conditions: Aseptic Revision Knee Arthroplasty, Stiffness Following Revision Knee Arthroplasty
Sponsor: Fu Jen Catholic University. Phase: NA. Conditions: Satisfaction, Personal
Sponsor: Haukeland University Hospital. Phase: PHASE1. Conditions: Multiple Sclerosis, Progressive Multiple Sclerosis
Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Lymphedema, Artificial Intelligence (AI)
Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Obesity, Non-Alcoholic SteatoHepatitis (NASH)
Sponsor: Eli Lilly and Company. Phase: PHASE4. Conditions: Atopic Dermatitis
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Artificial Intelegence
Sponsor: Boston Scientific Corporation. Phase: . Conditions: Arterial Occlusive Diseases, Atherosclerosis, Vascular Diseases, Arteriosclerosis
Sponsor: Acibadem University. Phase: NA. Conditions: Temporomandibular Disorders (TMD)
Sponsor: Pfizer. Phase: . Conditions: Ulcerative Colitis
Sponsor: Postgraduate Medical Institute, Lahore. Phase: NA. Conditions: Dentin Hypersensitivity, Post Operative Sensitivity Control
Sponsor: Indiana University. Phase: NA. Conditions: Anxiety, Well-Being, Satisfaction
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE2. Conditions: Perihilar Cholangiocarcinoma